Human gene therapy - JoVE Visualize

Showing results (2021-2030 of 4,124) with videos related to

Pageof 413

Sort By:

Human Gene Therapy|October 25, 2002

New oncolytic adenoviruses with hypoxia- and estrogen receptor-regulated replicationRuben Hernandez-Alcoceba, Michael Pihalja, Dalong Qian, et al.

Human Gene Therapy|June 12, 1999

Cardiac resistance to adriamycin in transgenic mice expressing a rat alpha-cardiac myosin heavy chain/human multiple drug resistance 1 fusion geneG Dell'Acqua, R Polishchuck, J T Fallon, et al.

Human Gene Therapy|June 12, 1999

Persistent delivery of factor IX in mice: gene therapy for hemophilia using implantable microcapsulesG Hortelano, N Xu, A Vandenberg, et al.

Human Gene Therapy|June 12, 1999

Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapyY K Tam, G Maki, B Miyagawa, et al.

Human Gene Therapy|March 4, 2000

Antiviral activity of an intracellularly expressed single-chain antibody fragment directed against the murine leukemia virus capsid proteinM Marin, M Pelegrin-Zurilla, E Bachrach, et al.

Human Gene Therapy|May 1, 1999

Efficient transduction of human lymphocytes and CD34+ cells via human immunodeficiency virus-based gene transfer vectorsJ Douglas, P Kelly, J T Evans, et al.

Human Gene Therapy|May 1, 1999

Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivoD A Muruve, M J Barnes, I E Stillman, et al.

Human Gene Therapy|May 1, 1999

Immunotherapy of metastatic malignant melanoma by a vaccine consisting of autologous interleukin 2-transfected cancer cells: outcome of a phase I studyS Schreiber, E Kämpgen, E Wagner, et al.

Human Gene Therapy|May 1, 1999

DeltaMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenograftsO N Koç, J S Reese, B M Davis, et al.

Human Gene Therapy|November 24, 1999

Enhancement of adenovirus-mediated gene delivery by use of an oligopeptide with dual binding specificityS S Hong, A Galaup, R Peytavi, et al.

Pageof 413

Showing results (2021-2030 of 4,124) with videos related to

Sort By:

Pageof 413

Human Gene Therapy|October 25, 2002

New oncolytic adenoviruses with hypoxia- and estrogen receptor-regulated replicationRuben Hernandez-Alcoceba, Michael Pihalja, Dalong Qian, et al.

Human Gene Therapy|June 12, 1999

Cardiac resistance to adriamycin in transgenic mice expressing a rat alpha-cardiac myosin heavy chain/human multiple drug resistance 1 fusion geneG Dell'Acqua, R Polishchuck, J T Fallon, et al.

Human Gene Therapy|June 12, 1999

Persistent delivery of factor IX in mice: gene therapy for hemophilia using implantable microcapsulesG Hortelano, N Xu, A Vandenberg, et al.

Human Gene Therapy|June 12, 1999

Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapyY K Tam, G Maki, B Miyagawa, et al.

Human Gene Therapy|March 4, 2000

Antiviral activity of an intracellularly expressed single-chain antibody fragment directed against the murine leukemia virus capsid proteinM Marin, M Pelegrin-Zurilla, E Bachrach, et al.

Human Gene Therapy|May 1, 1999

Efficient transduction of human lymphocytes and CD34+ cells via human immunodeficiency virus-based gene transfer vectorsJ Douglas, P Kelly, J T Evans, et al.

Human Gene Therapy|May 1, 1999

Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivoD A Muruve, M J Barnes, I E Stillman, et al.

Human Gene Therapy|May 1, 1999

Immunotherapy of metastatic malignant melanoma by a vaccine consisting of autologous interleukin 2-transfected cancer cells: outcome of a phase I studyS Schreiber, E Kämpgen, E Wagner, et al.

Human Gene Therapy|May 1, 1999

DeltaMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenograftsO N Koç, J S Reese, B M Davis, et al.

Human Gene Therapy|November 24, 1999

Enhancement of adenovirus-mediated gene delivery by use of an oligopeptide with dual binding specificityS S Hong, A Galaup, R Peytavi, et al.

Pageof 413